Institute for International Research

Attend This 3-day Event to Gain Insights Into:

1. Innovative Drug Discovery & Development in China - hear case studies on cancer, diabetes, and more from Shanghai Hengrui; Shenzhen Chipscreen and Shanghai Ambrosia.

2. Licensing to Co-Development Partnerships n R&D - develop your own operational strategy based on new partnerships and joint venture examples from European and Australian companies, as well as collaborations with academia and non-profit organizations.

3. Clinical Regulatory Affairs - attend an interactive panel discussion covering data harmonization, challenges in SFDA requirements for IND submissions, expediting NDA approvals, SFDA regulations on FIH trials etc.

4.Therapeutic Clinical Trials - showcasing current trials y Lundbeck, Novo Nordisk, Shanghai Genomics etc.

5. Adaptive Designs - attend this mini-workshop for an ntroduction to the taxonomy of adaptive designs with peakers from Sanofi-Aventis, Merck and US FDA.

6. Biologics Development Update in China - uncover the challenges and understand the expectations from big and small pharmas, presented by Simcere, Epitomics, 3SBio, T Mab, MedImmune, Merck, GSK, Beijing Novo Nordisk, ImClone Systems, Shanghai Celgen, Amgen, MediBiotech, PharmaLegacy and more!

7. China as the Innovation Center for Global Pharmaceutical R&D - showcasing panels on NCE Discovery, New Areas of Partnering and China's Life Sciences Investments.